Unlock stock picks and a broker-level newsfeed that powers Wall Street.

ASX - Delayed Quote AUD

ImpediMed Limited (IPD.AX)

0.0340
+0.0010
+(3.03%)
At close: 4:10:19 PM GMT+10

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.
NameTitlePayExercisedYear Born
Dr. Parmjot Bains M.D. MD, CEO & Director 431.45k -- --
Mr. McGregor Grant BEc, C.A., FCIS, GAICD CFO & Executive Director 415.85k -- --
Mr. Dennis Schlaht Senior Vice President of R&D and Technology 478.63k -- --
Ashley Munoz Director of Human Resources -- -- --
Dr. Steven Chen M.B.A., M.D. Chief Medical Center -- -- --
Ms. Leanne Ralph AAICD, ACIS, BBus Company Secretary -- -- --
Dr. Walton A. Taylor Medical Director -- -- --

ImpediMed Limited

5900 Pasteur Ct.
Suite 125
Carlsbad, CA 92008
United States
760 585 2100 https://www.impedimed.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
83

Description

ImpediMed Limited, a medical technology company, manufactures, and sells bioimpedance spectroscopy (BIS) technology medical devices in the Unites States and Europe. The company offers SOZO, a noninvasive BIS device for the clinical assessment of lymphedema and deliver snapshot of fluid status and tissue composition; L-Dex analysis for lymphedema; BodyComp Analysis, a point-of-car body composition analysis; and HF-Dex analysis for point-or care heart failure fluid assessment. It also provides SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. The company was incorporated in 1999 and is headquartered in Carlsbad, California.

Corporate Governance

ImpediMed Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 25, 2025 at 9:11 PM UTC

ImpediMed Limited Earnings Date

Recent Events

Related Tickers